The results of 98 ESCC samples by immunohistochemical analyses are in Table 1, and the patients were divided into two groups: high EHD2 expressers (score ≥ 2) and low EHD2 expressers (score < 2). This evidence concerns the gene EHD2 and esophageal squamous cell carcinoma.